Cite
APA Citation
Chaftari, A., Malek, A., Dagher, H., Jiang, Y., Bayle, A., Bhinder, A., Cruz, A. F., Siddiqui, B., Somer, R., Datoguia, T., Slavin, M., Dragvich, T., Gorak, E., Mori, N., Hachem, R. Y., & Raad, I. I. (n.d.). 293. Lung Cancer and Hematologic Malignancy ( HM) Patients Are Associated with the Highest Risk of Progressing to Severe Disease and Mortality in Cancer Patients with COVID-19. Open forum infectious diseases, 8, S254. http://access.bl.uk/ark:/81055/vdc_100150542820.0x000025